AI in Healthcare

The latest on artificial intelligence transforming medicine

News stories discovered and organized by an automated pipeline. Covering clinical deployments, research breakthroughs, regulation, and industry developments.

Filtered by: biotech fundingClear filter
industryForbes

Isomorphic Labs’ $2.1 Billion Round Signals AI Drug Discovery Is Entering Its Industrial Phase

Isomorphic Labs’ massive new financing is more than a headline-grabbing raise: it is a strong signal that investors believe AI-native drug discovery can become a durable platform business, not just a research experiment. The deal also underscores how concentrated the bet has become around a handful of companies that claim they can compress early discovery timelines and improve hit rates.

AI drug discoverybiotech fundingpharmaSeries B
industry

Isomorphic Labs’ $2.1 Billion Raise Signals AI Drug Discovery’s Coming Capital Arms Race

Isomorphic Labs has landed a massive $2.1 billion financing round, underscoring how much investor conviction now surrounds AI-native drug discovery. The deal is less about one company’s balance sheet than about a broader market belief that foundation-model methods can compress early R&D timelines and improve hit rates.

Forbes
AI drug discoverybiotech fundingIsomorphic Labs
industry

Isomorphic Labs Raises $2.1 Billion to Turn AI Drug Design Into a Clinical Business

Alphabet-backed Isomorphic Labs has raised $2.1 billion in one of the largest financing rounds ever for AI drug discovery. The size of the raise signals that investors are no longer funding only platform potential—they are underwriting the long, expensive transition from model development to clinical validation. The company now has the capital to push beyond headline-grabbing demonstrations and into the slower work of target selection, candidate optimization, and eventually human trials.

Reuters
AI drug discoverybiotech fundingAlphabet

How this works

Discover

An automated pipeline searches the web for significant AI healthcare news across clinical, research, regulatory, and industry domains.

Structure

The pipeline turns source material into concise, readable stories with categories, tags, and context that make the feed easier to scan.

Publish

Stories are deduplicated, stored, and published to this site. The pipeline runs automatically to keep coverage current.